NCT04590326: A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 612 planned
- Started
- 8 Dec 2020
- Primary completion
- 8 Nov 2028
- Arms
- Module 1
- Results
- None posted
- 19 Oct 2020: Trial registered
- 8 Dec 2020: Trial started